Menu
Not yet recruiting NCT07711756

Comparative Study of Adherence to Antibiotic Therapy Among Pediatric Patients: Hospital Emergency Department vs. Primary Care Center

Observational Tonsillitis Acute Pneumonia - Bacterial Otitis Media Acute Cystitis Acute

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Tonsillitis Acute, Pneumonia - Bacterial, Otitis Media Acute, Cystitis Acute. Basic parameters: 3 months — 16 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Comparative Study of Adherence to Antibiotic Therapy Among Pediatric Patients: The Gignac Primary Care Medical Center Versus the Pediatric Emergency Department of Montpellier University Hospital (CHU Montpellier).

Overview

This study was initiated because of the limited litterature available on this topic. The objective was to compare adherence to antibiotic therapy among a pediatric population treated in two healthcare settings in France: the Gignac Health Center, a primary care facility, and the Pediatric Emergency Department of Montpellier University Hospital. This observational study assessed treatment adherence through a telephone questionnaire administered to parents after the theorical end of the treatment.

Primary outcome measures

  • Proportion of patients who adhered to the antibiotic prescription provided by the general practitioner (GP) or the emergency physician (University Hospital) [Time frame: The study period extended from the initial consultation (antibiotic prescription) to 21 days after the prescription, depending on the prescribed treatment duration.]

Eligibility criteria

Inclusion criteria

  • Children aged 3 months to 16 years
  • Receiving an outpatient oral antibiotic prescription
  • Diagnosed with an acute bacterial infection

Exclusion criteria

  • Unemancipated minors presenting without a parent or legal guardian.
  • Participation in another clinical research study with an ongoing exclusion period
  • Refusal to participate after the reflection period
  • Parents unable to understand the study information (e.g., language barrier or cognitive impairment)
  • Not affiliated with, or not a beneficiary of, a national health insurance scheme
  • Pregnant or breastfeeding female participants

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07711756 · RECHMPL25_0564

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗